drugset / Trial / NCT00045617

S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

NCT00045617 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. Vaccines may make the body build an immune response to kill tumor cells. Combining chemotherapy and radiation therapy with vaccine therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining chemotherapy and radiation therapy with vaccine therapy in treating patients who have limited-stage small cell lung cancer.

Timeline

Start
2003-01
Primary completion
2003-05
Completion
2003-05

Outcome

Outcome not reported

Stopped: “Closed due to lack of drug availability.”

Drugs

EvaluationDrugModalityDoseRoute
Subject 11D10 Monoclonal antibody — Other
Subject Cisplatin Other / unclassified — Intravenous
Subject Etoposide Small molecule — Intravenous
Subject GD2 Vaccine — Other

Indications